Panelists discuss how modern FDA-approved intravenous iron formulations, including ferric carboxymaltose, ferumoxytol, and ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

Panelists discuss how oral iron therapy, although convenient and cost-effective, has significant limitations, including ...

Sen. Bill Cassidy, MD, (R, Louisiana) holds a key vote on Robert F. Kennedy Jr's HHS Secretary confirmation. When Cassidy ...

The issue will feature guest editor Nate Apathy, Ph.D., from the University of Maryland School of Public Health in College ...

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

Although long-term nursing home stay or death decreased before the COVID-19 pandemic, the trend slowed during the pandemic ...

The design of the Enhancing Oncology Model (EOM) was a perfect fit for Minnesota Oncology.

Panelists discuss how switching therapies in patients with alopecia areata (AA) is often necessary when initial treatments ...

Extranodal non-Hodgkin lymphoma (NHL) makes up over one-third of NHL cases, yet remains understudied and in need of deeper ...

Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at Mayo Clinic, suggests that medical providers can reduce patient ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...